Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Ethosuximide
Drug ID BADD_D00846
Description An anticonvulsant especially useful in the treatment of absence seizures unaccompanied by other types of seizures.
Indications and Usage For the treatment of petit mal epilepsy.
Marketing Status Prescription
ATC Code N03AD01
DrugBank ID DB00593
KEGG ID D00539
MeSH ID D005013
PubChem ID 3291
TTD Drug ID D0Q4XQ
NDC Product Code 61748-025; 64380-878; 10888-8169; 49452-2803; 69452-152; 71335-1763; 0071-0237; 0071-2418; 42806-711; 63629-8005; 51927-3436; 59762-2350; 11014-0047; 17349-0006; 59762-2250; 0121-0670; 23155-532
Synonyms Ethosuximide | Ethosuccimid | Ethylmethylsuccimide | Ethymal | Zarontin | Petnidan | Pyknolepsinum | Suksilep | Suxilep | Emeside | Etosuximida Faes | Faes, Etosuximida
Chemical Information
Molecular Formula C7H11NO2
CAS Registry Number 77-67-8
SMILES CCC1(CC(=O)NC1=O)C
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Sleep disorder19.02.04.001--Not Available
Sleep terror19.02.03.008; 17.15.02.006--Not Available
Somnolence19.02.05.003; 17.02.04.006--
Stevens-Johnson syndrome23.03.01.007; 12.03.01.014; 11.07.01.005; 10.01.03.020--
Suicidal ideation19.12.01.0030.019368%
Swollen tongue23.04.01.014; 10.01.05.015; 07.14.02.003--Not Available
Systemic lupus erythematosus23.03.02.006; 15.06.02.003; 10.04.03.0040.019368%Not Available
Thrombocytopenia01.08.01.0020.019368%Not Available
Tongue disorder07.14.01.002--Not Available
Tongue oedema23.04.01.009; 10.01.05.008; 07.14.02.007--Not Available
Tremor17.01.06.0020.019368%
Urethral disorder20.07.01.002--Not Available
Urinary tract disorder20.08.01.001--Not Available
Urticaria23.04.02.001; 10.01.06.001--
Vaginal haemorrhage24.07.03.005; 21.08.01.001--
Vomiting07.01.07.0030.058104%
Weight decreased13.15.01.005--
Lymphatic disorder01.09.01.003--Not Available
Gastric disorder07.11.01.003--Not Available
Disturbance in sexual arousal19.08.04.003--Not Available
Antinuclear antibody positive13.06.01.0030.019368%Not Available
Breast disorder21.05.04.004--Not Available
Connective tissue disorder15.06.01.006--Not Available
Malnutrition14.03.02.004--Not Available
Mediastinal disorder22.09.03.001--Not Available
Mental disorder19.07.01.002--Not Available
Decreased appetite14.03.01.005; 08.01.09.0280.019368%
Blood disorder01.05.01.004--Not Available
Psychotic disorder19.03.01.002--
Bone marrow failure01.03.03.005--
The 3th Page    First    Pre   3 4    Next   Last    Total 4 Pages